Magnesium Lactate
CAS 18917-93-6
Magnesium Lactate (CAS 18917-93-6) is a pharmaceutical compound with 0 bioactivity targets and 10 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Premature baby | 23 | 83.483 | 10036590 |
| Bronchopulmonary dysplasia | 8 | 49.845 | 10006475 |
| Oligohydramnios | 10 | 49.251 | 10030289 |
| Umbilical hernia | 10 | 47.502 | 10045458 |
| Foetal growth restriction | 11 | 46.817 | 10070531 |
| Neonatal respiratory distress syndrome | 9 | 42.26 | 10028974 |
| Atrial septal defect | 10 | 40.228 | 10003664 |
| Maternal exposure during pregnancy | 19 | 39.948 | 10071408 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| magnesium lactate | 214688 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Magnesium Lactate used for in pharmaceutical contexts?
Magnesium Lactate (CAS 18917-93-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Magnesium Lactate?
Magnesium Lactate has 10 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Premature baby, Bronchopulmonary dysplasia, Oligohydramnios, Umbilical hernia, Foetal growth restriction. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Magnesium Lactate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Magnesium Lactate with EU status "permitted".
What clinical phase is Magnesium Lactate in?
No phase 1-4 clinical development badge is rendered for Magnesium Lactate because the matched compound identifier rows do not contain a max-phase value.